BrianCell Therapeutics股价下跌10%，售价3000万美元，每单位5.59美元

2026-01-14 14:35

BriaCell Therapeutics (BCTX) priced a public offering of 5.37M units, with each unit consisting of one common share and one warrant.
Each unit is being sold to the public at a price of $5.59 per unit for gross proceeds of ~$30M.
The offering is expected to close on January 15, 2026.
The company intends to use the net proceeds to fund working capital requirements, general corporate purposes and the advancement of the company’s business objectives.
The stock price dropped 9.7% on Tuesday during after-market hours of trading.

More on BriaCell Therapeutics Corp.